๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Monoclonal antibody DF3 correlates with tumor differentiation and hormone receptor status in breast cancer patients

โœ Scribed by Joel Lundy; Ann Thor; Ronald Maenza; Jeffrey Schlom; Faripour Forouhar; Marcia Testa; Donald Kufe

Publisher
Springer US
Year
1985
Tongue
English
Weight
885 KB
Volume
5
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Tumor hormone receptor status and recurr
Tumor hormone receptor status and recurrences in premenopausal patients with node-negative breast carcinoma
โœ Theodore N. Tsangaris; Sally M. Knox; J. Harold Cheek ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 391 KB ๐Ÿ‘ 2 views

To ascertain the prognostic significance of tumor hormone receptor status in premenopausal patients with node-negative breast cancer, a retrospective review of 199 patients who met these criteria was conducted. Of these 199 patients, estrogen receptor (ER) data were available for 147. One hundred fo

Stage-dependent depression of melatonin
Stage-dependent depression of melatonin in patients with primary breast cancer. Correlation with prolactin, thyroid stimulating hormone, and steroid receptors
โœ Christian Bartsch; Hella Bartsch; Ute Fuchs; Theodor H. Lippert; Otto Bellmann; ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 816 KB

Serum melatonin was determined over 24 hours in 35 patients with breast cancer with either a fresh primary tumor (n = 23) or a secondary tumor (n = 12) and in 28 patients with untreated benign breast disease (controls) having a fibroadenoma (n = lo), fibrocystic mastopathy (n = 14), or other breast